How Do Modifiable Risk Factors Affect Alzheimer’s Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?

2023/09/07 by Valentin Ourry, Alexa Pichet Binette, Frédéric St‐Onge +15 · 15 citations
Medicine · #Dementia and Cognitive Impairment Research #Frailty in Older Adults #Diet and metabolism studies

paper · doi:10.1016/j.biopsych.2023.09.003

Cited by

• Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease
• Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging
• Associations of lifestyle factors with amyloid pathology in persons without dementia
• Structural white matter properties and cognitive resilience to tau pathology. [europepmc]
• Apathy Associated with Alzheimer's Disease. [europepmc]
• Loneliness and Biomarkers of Alzheimer's Disease, Axonal Damage, and Astrogliosis: A Coordinated Analysis of Two Longitudinal Cohorts. [europepmc]
• World no-tobacco: effects of second-hand smoke (SHS) and vapors on the developing and adult brain. [europepmc]
• Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging. [europepmc]
• Factor analysis of multimodal MRI, biofluid, and vascular biomarkers reveals latent constructs of brain health. [europepmc]
• Insulin-like Growth Factor 1 Impact on Alzheimer's Disease: Role in Inflammation, Stress, and Cognition. [europepmc]
• PolyGR-containing aggregates link with pathology and clinical features of Alzheimer's disease. [europepmc]
• Modifiable Factors Associated with the Longitudinal Increase and Spatial Extent of Tau Pathology in Alzheimer Disease. [europepmc]
• The role of genomic-informed risk assessments in predicting dementia outcomes. [europepmc]
• Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers. [europepmc]
• Purpose in life and blood-based biomarkers of brain health. [europepmc]